Boothbay Fund Management’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAW
LCM
Boothbay Fund Management's TRAW Position: Q3 2026 in Review
Boothbay Fund Management held its Traws Pharma (TRAW) position steady in Q3 2026 at 133,936 shares worth $79.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1827.
Boothbay Fund Management first reported a position in TRAW in Q1 2021 and has held it in 7 quarters since. The position peaked at $356K in Q1 2026. 34 funds tracked by Wall St. Rank hold TRAW as of Q3 2026.
- Boothbay Fund Management held 133,936 shares of Traws Pharma worth $79.5K as of Q3 2026.
- Boothbay Fund Management left its Traws Pharma share count unchanged in Q3 2026.
- Traws Pharma made up ﹤0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1827 holding.
- Boothbay Fund Management first reported a position in Traws Pharma in Q1 2021 and has held it in 7 quarters since.
- Boothbay Fund Management's Traws Pharma position peaked at $356K in Q1 2026.
- 34 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.